Dow Jones received a payment from EQS/DGAP to publish this press release.
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES
AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
01-Feb-2019 / 12:18 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France
DECLARATION RELATIVE TO
THE NUMBER OF SHARES AND VOTING RIGHTS
MAKING UP THE ISSUED CAPITAL
Article L 233-8-II of the Code of commerce
and article 223-6 of the general regulations of the AMF
Designation of issuer
SARTORIUS STEDIM BIOTECH SA
CS 91051
Z. I. Les Paluds
Avenue de Jouques
13781 Aubagne Cedex
Date of Total number of Total number of Total number
information shares making theoretical of net voting
up the issued voting rights rights
capital including
treasury shares
January 31, 2019 92,180,190 161,024,614 161,021,248
Regulatory filing PDF file
Document title: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING
RIGHTS MAKING UP THE ISSUED CAPITAL
Document: http://n.eqs.com/c/fncls.ssp?u=JJFPOBNEVO [1]
Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: info@sartorius-stedim.com
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext Ticker: DIM
AMF Category: Other news releases
End of Announcement EQS News Service
771803 01-Feb-2019 CET/CEST
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=93b085b913962cfc47383f5161eeaa60&application_id=771803&site_id=vwd&application_name=news
(END) Dow Jones Newswires
February 01, 2019 06:18 ET (11:18 GMT)
